StreetInsider.com News Articles

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

HOUSTON, May 19, 2026 /PRNewswire/ -- Stellus Capital Management, LLC ("Stellus" or the "Firm"), a leader in lower middle market direct lending, today announced the final close of Stellus Credit Fund IV ("SCF IV" or the "Fund"). The Firm met its fundraising target with approximately $1.5 billion of investable capital. SCF IV, the successor to Stellus Credit Fund III, closed on April 1, 2026, and has already invested in 44 portfolio companies.

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Stellus Capital Management Closes Stellus Credit Fund IV

Tue, 19 May 2026 10:54:00 -0400

Firm Hits Fundraising Target with Approximately $1.5 Billion of Investable Capital¹

Form 10-Q Ridgepost Capital, Inc. For: Mar 31

Fri, 08 May 2026 12:00:00 -0400

si-local-file:///var/storage/secattach/20260508/26459611.html

Form 10-Q Ridgepost Capital, Inc. For: Mar 31

Fri, 08 May 2026 12:00:00 -0400

si-local-file:///var/storage/secattach/20260508/26459611.html

Form 10-Q Ridgepost Capital, Inc. For: Mar 31

Fri, 08 May 2026 12:00:00 -0400

si-local-file:///var/storage/secattach/20260508/26459611.html

Radient Pharmaceuticals (RPC) PT Raised to $17 at Oppenheimer

Fri, 08 May 2026 08:14:43 -0400

Oppenheimer raised its price target on Radient Pharmaceuticals (NYSE: RPC) to $17.00 (from $16.00) while maintaining a Outperform rating.

Form 8-K Ridgepost Capital, Inc. For: May 07

Fri, 08 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260508/26457993.html

Form 8-K Ridgepost Capital, Inc. For: May 07

Fri, 08 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260508/26457993.html

Form 8-K Ridgepost Capital, Inc. For: May 07

Fri, 08 May 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260508/26457993.html

Radient Pharmaceuticals (RPC) PT Raised to $12 at Barclays

Fri, 08 May 2026 04:07:50 -0400

Barclays raised its price target on Radient Pharmaceuticals (NYSE: RPC) to $12.00 (from $11.00) while maintaining a Overweight rating.

Ridgepost Capital Announces First Quarter 2026 Results

Thu, 07 May 2026 06:30:00 -0400

DALLAS, May 07, 2026 (GLOBE NEWSWIRE) -- Ridgepost Capital, Inc (NYSE: RPC), a leading private markets solutions provider, today announced financial results for the first quarter ended March 31, 2026.

A presentation of the quarterly financials may be accessed here and is available at https://ir.ridgepostcapital.com/quarterly-results.

“Ridgepost Capital delivered record fundraising levels to start 2026,” said Luke Sarsfield, Ridgepost Capital Chairman and Chief Executive Officer. “Fee-paying assets under management stood at approximately $31 billion at quarter-end, surpassing $30 billion for the first time and representing

Ridgepost Capital Announces First Quarter 2026 Results

Thu, 07 May 2026 06:30:00 -0400

A presentation of the quarterly financials may be accessed here and is available at https://ir.ridgepostcapital.com/quarterly-results.

Ridgepost Capital Announces First Quarter 2026 Results

Thu, 07 May 2026 06:30:00 -0400

A presentation of the quarterly financials may be accessed here and is available at https://ir.ridgepostcapital.com/quarterly-results.